DOL Signals July 10 as End of COVID-19 Outbreak Period, Despite Early End to National Emergency - Bim Group

DOL Signals July 10 as End of COVID-19 Outbreak Period, Despite Early End to National Emergency

READ TIME: 6 MINUTES

On Monday, April 10, 2023, President Biden signed Congress’s jointly-introduced H.J Res. 7 into law, ending the COVID-19 National Emergency immediately instead of on May 11, 2023, as previously announced. However, the Department of Labor (DOL) has unofficially signaled that its previous guidance issued on March 29, 2023, stands, including guidance that the Outbreak Period will end on July 10, 2023. As background, the end of the Outbreak Period is significant because that is the date that plan sponsors are no longer required to offer a one-year extension of deadlines relating to COBRA elections and premium payments, HIPAA special enrollment elections and ERISA claims procedures. With the earlier end to the National Emergency, there has been some confusion regarding whether the July 10, 2023, date is the appropriate end of the Outbreak Period or whether it should be June 9, 2023, which is 60 days after the actual end of the National Emergency on April 10, 2023.

Based on the informal communications from the DOL, it appears that employers may continue to rely on the prior guidance from the DOL that the end of the Outbreak Period is July 10, 2023. Employers who have already started working with their COBRA administrators and other vendors to provide notices regarding the expiration of the extended deadlines and amend plan documents in accordance with earlier guidance would potentially experience unnecessary costs and create confusion among employees if the DOL announced on short notice that the end of the Outbreak Period was accelerated to June 9, 2023. Further, the DOL and other federal agencies have expressly encouraged employers to voluntarily extend these deadlines after the end of the Outbreak Period to allow employees more time to pay COBRA premiums, retroactively elect COBRA, or enroll in group health benefits under a HIPAA special enrollment right, for example. Accordingly, it would be inconsistent with the stated policy goals of the federal agencies to accelerate the date of the required deadline extensions.

On the other hand, employers and stakeholders who have long assumed that the end of the Outbreak Period would be 60 days after the end of the National Emergency may be questioning why it now appears the DOL is sticking with its originally announced date of July 10, 2023. The answer is that it appears the federal agencies always anticipated that end of the Outbreak Period may end on a date that they announce rather than being strictly tied to 60 days after the National Emergency ends. In both the original DOL announcement regarding the extension of deadlines (EBSA Disaster Relief Notice 2020-01) and the most recent federal agency guidance issued on March 29, 2023, the end of the Outbreak Period is defined as 60 days after the announced end of the National Emergency or another date announced by the DOL, Department of Health and Human Services or the Department of the Treasury. Accordingly, unless and until further guidance or notice is issued, it should be reasonable to rely on the guidance of the FAQs About Families First Coronavirus Response Act, Coronavirus Aid, Relief, and Economic Security Act, and Health Insurance Portability and Accountability Act Implementation, Part 58 (FAQS) and utilize July 10, 2023, as the announced date of the official end of the Outbreak Period.

What Should Employers Do Now?

For employers, the end of the National Emergency is linked to the end of the required extension of deadlines for COBRA, HIPAA special enrollment rights, claims, and other ERISA disclosures. The end of the Public Health Emergency ends the mandates to cover certain COVID-19 testing and supplies at no cost, as well as other pandemic-related relief. Employers should already be preparing for the end of both the National Emergency and the Public Health Emergency as addressed in our earlier Advisor on the FAQs. As a reminder, our prior Advisor recommended that employers should be taking steps now to:

Analyze whether to impose permitted cost-sharing, prior authorization or other medical management requirements for COVID-19 diagnostic tests or provide other relief suggested by the FAQ such as continued extension of applicable deadlines for claims, COBRA and HIPAA special enrollment.

  • Work with plan advisors to implement the changes to ensure that insurance carriers, including stop loss carriers, are on board with any COVID-19 enhancements the plan sponsor chooses to keep in place.
  • Review plan documents and employee communications, including summary plan descriptions, to determine whether amendments are required to reflect the changes (note that language providing that the enhanced benefits only apply during the National Emergency and Public Health Emergency periods may not need to be amended).
  • Immediately communicate changes in group health plan benefits and deadlines for claims, COBRA, and HIPAA special enrollment resulting from the end of the Public Health Emergency and National Emergency.
  • Review and update current COBRA notices to reflect the end of the Outbreak Period and work with your COBRA administrator to communicate with impacted qualified beneficiaries regarding the end of extended deadlines to make coverage elections and pay premiums.

Because it is unclear whether the agencies will issue additional guidance regarding the early end of the National Emergency and whether that impacts the timing of the end of the Outbreak Period, employers should take the following additional steps:

  1. Reevaluate plan language regarding the extensions of deadlines to see if amendments are required. As noted above, the FAQs had stated that plan language providing that the extensions would automatically expire at the end of the Outbreak Period may not need to be amended. However, employers should review how the Outbreak Period was defined in their plan language as an amendment may now be required if the end of the Outbreak Period was defined as 60 days following the end of the National Emergency without the caveat that it could be a different date announced by the federal agencies.
  2. Work with advisors to communicate with insurance carriers and stop loss carriers regarding the use of the July 10, 2023, date as the end of the Outbreak Period to ensure there is no potential gap in coverage or question regarding the applicable deadline for HIPAA special enrollment elections, claims and appeals, and COBRA elections and premium payments.

With this area quickly evolving, it will be important to stay abreast of potentially changing deadlines or employer requirements. We will continue to issue updates as relevant guidance is issued.

 

This information has been prepared for UBA by Fisher & Phillips LLP. It is general information and provided for educational purposes only. It is not intended to provide legal advice. You should not act on this information without consulting legal counsel or other knowledgeable advisors.

Recent Insights

November 29, 2023
News

Important Reminder: Gag Clause Attestation Due 12/31/23

The Consolidated Appropriations Act of 2021 (the CAA) requires group health plans to attest compliance with the CAA’s gag clause prohibition on an annual basis. While the prohibition of gag clauses was effective December 27, 2020, the first annual attestation is due December 31, 2023. Group health plan sponsors should begin taking steps now to […]
Read more
November 20, 2023
News

New PCORI Fee Announced by IRS

READ TIME:  7 MINUTES The Internal Revenue Service (IRS) recently released the adjusted Patient-Centered Outcomes Research Institute (PCORI) fee rate for policy and plan years ending on or after October 1, 2023, and before October 1, 2024. Background The Affordable Care Act (ACA) imposed a fee on issuers of fully insured plans and plan sponsors […]
Read more
November 20, 2023
HHS

HHS Announces Civil Penalties for HIPAA, ACA, and MSP Violations

READ TIME: 5 MINUTES On October 6, 2023, the Department of Health and Human Services (HHS) released inflation-related penalty adjustments for violations of the Health Insurance Portability and Accountability Act (HIPAA), Affordable Care Act (ACA), and the Medicare Secondary Payer (MSP) rules. These adjusted amounts apply to penalties assessed on or after October 6, 2023, […]
Read more
November 20, 2023
Webinar

Webinar: Year-End Compliance and What to Expect in 2024

Tuesday, December 12, 2023 1 – 2PM CST Register Now Registration Code:UBA410EW   Attend this month’s webinar to review 2023 employee benefits compliance requirements and learn about compliance challenges employers will face in 2024. Gain insights into: Reproductive healthcare and contraceptive coverage requirements Prescription drug and healthcare reporting Consolidated Appropriations Act components that may impact […]
Read more